An Open Label Study of Bavituximab and Pembrolizumab in Advanced Gastric and GEJ Cancer Patients
Clinical trial NCT04099641 · COMPLETED
Trial details
- NCT number
- NCT04099641
- Sponsor
- OncXerna Theraputics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-11
- Primary completion
- 2021-12-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.